NR 501 WEEK 7 THEORETICAL FRAMEWORK POWERPOINT PRACTICE SOLUTION 2026 EVALUATED WORK GRADED A+

NR 501 WEEK 7 THEORETICAL FRAMEWORK
POWERPOINT PRACTICE SOLUTION 2026
EVALUATED WORK GRADED A+

◉ Type 1 insulin therapy goals a1c. Answer: 80-130


◉ Typle 1 insulin therapy goals 2hpp. Answer: <180


◉ type 1 insulin therapy goals A1C. Answer: <7%


◉ Diabetes type1a. Answer: insulin dependent


◉ diabetes type 1b. Answer: variably insulin dependent


◉ First line treatment for type 2 diabetes?. Answer: lifestyle
managment
weight loss of at least 5%


◉ Metformin not used with an eGFR below??. Answer: 45/ 1.73


◉ Typle 2 diabetes a1c strong control. Answer: less than 7%

,◉ type 2 diabetes decrease complications a1c?. Answer: 6.5% or less


◉ Single dose therapy. Answer: intermediate or long acting insulin
check blood sugar at least once in the morning and at bedtime


◉ conventional split dose therapy. Answer: two injections- NPH and
Regular


◉ intensive insulin therapy. Answer: three injections
regular insulin in the morning and dinner
NPH at bedtime


◉ Intensive insulin therapy 4 injections. Answer: regular or lispro
before meals and long acting to maintain


◉ Treatment goals healthy individuals (type 2). Answer: a1c <7.5
fasting 90-130
Bedtime 90-150
bp< 140/90


◉ Treatment goals complex type 2. Answer: a1c< 8

, fasting 90-150
bedtime 100-180
use statin!


◉ Treatment goals very complext. Answer: (LTC or end stage)
a1c (8.5%
fasting 100-180
bedtime 110-200
bp <150/90


◉ Pregnancy a1c goals. Answer: <6


◉ Men <50 rarely get UTI's except with. Answer: urinary catheters,
anatomical abnormalities of urinary tract, unprotected anal
intercourse, vaginal intercourse with a woman who has a bacterial
infection


◉ Incidence of UTI in men. Answer: 20%
lifetme prevalence of 1%


◉ Incidence of UTI in postmenopausal women. Answer: 0.07-0.13
women/year